|
TM2D2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5163004185581E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.09660100181486E-11 |
| Normal-vs-Stage2 |
7.85580000000063E-05 |
| Normal-vs-Stage3 |
3.811600E-04 |
| Normal-vs-Stage4 |
3.57020000000263E-05 |
| Stage1-vs-Stage2 |
4.754400E-01 |
| Stage1-vs-Stage3 |
1.053790E-01 |
| Stage1-vs-Stage4 |
8.301000E-01 |
| Stage2-vs-Stage3 |
5.563200E-01 |
| Stage2-vs-Stage4 |
5.075600E-01 |
| Stage3-vs-Stage4 |
2.449200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.07790509430129E-11 |
| Normal-vs-AfricanAmerican |
1.47359999980168E-07 |
| Normal-vs-Asian |
1.638410E-04 |
| Caucasian-vs-AfricanAmerican |
3.471800E-01 |
| Caucasian-vs-Asian |
4.986600E-01 |
| AfricanAmerican-vs-Asian |
3.582600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.33375599032615E-12 |
| Normal-vs-Female |
2.4641000000436E-06 |
| Male-vs-Female |
3.235000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.90020000027047E-07 |
| Normal-vs-Extreme_Weight |
2.00950034390246E-10 |
| Normal-vs-Obese |
2.24859999509164E-08 |
| Normal-vs-Extreme_Obese |
3.70570000018944E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.771200E-01 |
| Normal_Weight-vs-Obese |
9.651200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.101800E-01 |
| Extreme_Weight-vs-Obese |
3.860400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.494000E-01 |
| Obese-vs-Extreme_Obese |
1.590830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.224550E-01 |
| Normal-vs-Age(41-60Yrs) |
2.20689999608226E-08 |
| Normal-vs-Age(61-80Yrs) |
1.53279611225798E-11 |
| Normal-vs-Age(81-100Yrs) |
4.18159999999723E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.656400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.225640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.927600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.325440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.382200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.502800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.03725925018716E-12 |
| Normal-VS-Type2 PRCC |
2.36360000016589E-07 |
| Normal-VS-KIRP CIMP |
7.933000E-01 |
| Normal-VS-Unclassified PRCC |
3.39939999483008E-08 |
| Type1 PRCC-VS-Type2 PRCC |
5.511900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.76430000000361E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.010600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.994030E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.485600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.800100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04730000005659E-07 |
| Normal-vs-N1 |
3.333800E-02 |
| Normal-vs-N2 |
1.923610E-02 |
| N0-vs-N1 |
4.330100E-02 |
| N0-vs-N2 |
7.306200E-01 |
| N1-vs-N2 |
5.720200E-01 |
|
|
